All In Biotech

Drug Trial Radar · NCT01341782

Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

Last checked: Nov 19, 2026Latest source record: Jun 6, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 255 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

255

Actual

Start

May 2011

Primary completion

Apr 2012

Study completion Apr 2012

Sponsor

Lead sponsor
AbbVie (prior sponsor, Abbott)AbbVie (ABBV)
Sponsor type
Industry
First posted
Apr 26, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a comparison of the efficacy and safety of paricalcitol injection with maxacalcitol injection in adult Japanese chronic kidney disease patients receiving hemodialysis with secondary hyperparathyroidism. The main objective of this study is to demonstrate the efficacy of paricalcitol injection in reducing levels of parathyroid hormone without clinically significant hypercalcemia, compared to maxacalcitol injection.

Conditions

  • Secondary Hyperparathyroidism
  • Hemodialysis

Interventions

  • paricalcitolDrug

  • maxacalcitolDrug

  • paricalcitol placeboDrug

  • maxacalcitol placeboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Target Intact Parathyroid Hormone (iPTH) and Without HypercalcemiaTime frame: iPTH measured during the last three weeks of treatment (Weeks 11, 12, and 13). Calcium measured throughout the study (Weeks 1-13).

Locations

45 sites in 1 country. Site status is shown where the registry gives one.

  • Site Reference ID/Investigator# 53485

    Aichi, Japan

  • Site Reference ID/Investigator# 51571

    Chiba, Japan

  • Site Reference ID/Investigator# 52963

    Chiba, Japan

  • Site Reference ID/Investigator# 52966

    Chiba, Japan

  • Site Reference ID/Investigator# 51578

    Gifu, Japan

  • Site Reference ID/Investigator# 52965

    Gunma, Japan

  • Site Reference ID/Investigator# 53782

    Hadano, Japan

  • Site Reference ID/Investigator# 57483

    Himeji, Japan

  • Site Reference ID/Investigator# 57487

    Hokkaido, Japan

  • Site Reference ID/Investigator# 53484

    Hyōgo, Japan

  • Site Reference ID/Investigator# 54385

    Ibaraki, Japan

  • Site Reference ID/Investigator# 51581

    Kagawa, Japan

  • Site Reference ID/Investigator# 59164

    Kagoshima, Japan

  • Site Reference ID/Investigator# 51574

    Kanagawa, Japan

  • Site Reference ID/Investigator# 51575

    Kanagawa, Japan

  • Site Reference ID/Investigator# 52751

    Kodaira, Japan

  • Site Reference ID/Investigator# 62025

    Koga, Japan

  • Site Reference ID/Investigator# 54384

    Matsumoto, Japan

  • Site Reference ID/Investigator# 52745

    Midori, Japan

  • Site Reference ID/Investigator# 51569

    Mito, Japan

  • Site Reference ID/Investigator# 52964

    Nagano, Japan

  • Site Reference ID/Investigator# 53483

    Nagano, Japan

  • Site Reference ID/Investigator# 51582

    Nagasaki, Japan

  • Site Reference ID/Investigator# 54388

    Nagoya, Japan

  • Site Reference ID/Investigator# 51576

    Niigata, Japan

  • Site Reference ID/Investigator# 51577

    Niigata, Japan

  • Site Reference ID/Investigator# 51580

    Osaka, Japan

  • Site Reference ID/Investigator# 52747

    Osaka, Japan

  • Site Reference ID/Investigator# 52748

    Osaka, Japan

  • Site Reference ID/Investigator# 52750

    Osaka, Japan

  • Site Reference ID/Investigator# 51570

    Saitama, Japan

  • Site Reference ID/Investigator# 54387

    Sakai, Japan

  • Site Reference ID/Investigator# 52746

    Sapporo, Japan

  • Site Reference ID/Investigator# 51579

    Shizuoka, Japan

  • Site Reference ID/Investigator# 62024

    Takasaki, Japan

  • Site Reference ID/Investigator# 51572

    Tokyo, Japan

  • Site Reference ID/Investigator# 52752

    Tokyo, Japan

  • Site Reference ID/Investigator# 53482

    Tokyo, Japan

  • Site Reference ID/Investigator# 59162

    Tokyo, Japan

  • Site Reference ID/Investigator# 59966

    Tokyo, Japan

Showing 40 of 45 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.